Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

NCT02227641 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Patients Undergoing Allogeneic Stem Cell Transplantation

Interventions

BIOLOGICAL: CMV/EBV specific T-cell

Sponsor

University of Erlangen-Nürnberg Medical School

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]